VBI VACCINES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.574 USD | -4.24% |
|
-9.42% | -2.30% |
| 16/04 | VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 15/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar VBI Vaccines Inc.
b1373.hGY-IwNgfPbSDXwqP4XedXQ6OZv9sDNRCkDbkYKzkWM.wT8KEUUGGJ60PzBpVujtJzgNTdqK4nBkPiqR6dGH1gLrDEpwbVkqr55XLQ~ed4722696b36101e51429cf8efa88dd0
Upcoming events on VBI Vaccines Inc.
Past events on VBI Vaccines Inc.
| 16/04/2024 05:30 pm | Q4 2023 Earnings Release |
| 03/04/2024 10:40 pm | World Vaccine Congress |
| 17/11/2023 | Society for Neuro-Oncology Meeting |
| 15/11/2023 02:50 am | Q3 2023 Earnings Release |
| 14/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 23/06/2023 08:30 pm | Annual General Meeting |
| 21/06/2023 12:30 pm | European Association for the Study of the Liver Congress - Abstract Number: 3788 |
| 15/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 12/04/2023 | Reverse Split: 1 of 30 |
| 13/03/2023 05:30 pm | Q4 2022 Earnings Release |
| 28/02/2023 11:30 pm | Investor Meeting - Raymond James & Associates, Inc. |
| 18/02/2023 11:40 am | Conference of the Asian Pacific Association for the Study of the Liver |
| 18/11/2022 | Society for Neuro Oncology Meeting - Poster Number CTIM-14 |
| 16/11/2022 01:30 pm | Jefferies London Healthcare Conference |
| 16/11/2022 01:50 am | Guggenheim Immunology and Neurology Conference |
| 10/11/2022 06:30 pm | Q3 2022 Earnings Release |
| 18/10/2022 06:30 pm | H.C. Wainwright Hepatitis B Virus Conference |
| 19/09/2022 | International HBV Meeting |
| 08/08/2022 05:30 pm | Interim 2022 Earnings Release |
| 26/06/2022 02:30 pm | European Association for the Study of the Liver International Liver Congress - Abstract Number: 1416 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,22 2,64 -15.93% | 1,06 1,26 -15.94% | 0,63 0,80 -21.13% | 1,08 1,00 8.2% | 8,68 13,0 -33.22% | 14,5 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -52,4 -52,0 -0.74% | -43,6 -42,8 -1.94% | -68,0 -65,0 -4.68% | -81,8 -76,3 -7.23% | -79,9 -69,7 -14.71% | -37,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,8 -53,5 -2.47% | -46,2 -45,1 -2.41% | -69,8 -70,0 0.31% | -113 -93,3 -21.45% | -92,8 -98,3 5.54% | -42,8 |
|
Net income Million USD | Released Forecast Spread | -54,8 -53,9 -1.62% | -46,2 -44,8 -3.17% | -69,8 -70,0 0.31% | -113 -93,3 -21.45% | -93,8 -98,3 4.52% | -42,8 |
|
EPS USD | Released Forecast Spread | -13,8 -13,8 0% | -6,30 -6,06 -3.96% | -8,10 -8,20 1.22% | -13,2 -10,1 -31.34% | -6,03 -6,59 8.5% | -1,39 |
| Announcement Date | 05/03/20 | 02/03/21 | 07/03/22 | 13/03/23 | 16/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 0,14 -41.02% | 0,13 0,09 45.38% | 0,35 0,70 -50.88% | 0,32 1,29 -75.48% | 0,29 0,56 -47.58% | 0,49 0,82 -40.64% | 0,72 0,93 -22.5% | 6,62 13,3 -50.01% | 0,85 5,36 -84.09% | 2,85 | 3,19 | 3,88 | 4,56 | 6,55 |
|
EBIT Million USD | Released Forecast Spread | -20,9 -17,8 -17.22% | -15,9 -19,7 19.15% | -22,9 -16,7 -37.49% | -21,6 -20,3 -6.04% | -21,4 -19,6 -9.6% | -19,5 -18,7 -4.19% | -17,0 -17,2 1.19% | -6,47 -1,78 -263.43% | -13,4 -3,11 -329.43% | -10,3 | -9,85 | -9,08 | -8,31 | -6,59 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,8 -19,0 1.05% | -21,3 -20,8 -2.15% | -45,7 -17,4 -162.36% | -25,2 -21,0 -19.78% | -21,1 -21,8 3.07% | -27,8 -19,4 -42.74% | -44,6 -18,7 -139.22% | -20,4 -3,28 -522.91% | -0,01 -4,59 99.72% | -11,4 | -11,2 | -10,5 | -9,72 | -7,95 |
|
Net income Million USD | Released Forecast Spread | -18,8 -19,0 1.05% | -21,3 -20,8 -2.15% | -45,7 -17,4 -162.36% | -25,2 -21,0 -19.78% | -21,1 -21,8 3.07% | -27,8 -19,4 -42.74% | -44,6 -18,7 -139.22% | -21,3 -3,28 -549.18% | -0,16 -4,59 96.6% | -11,4 | -11,2 | -10,5 | -9,72 | -7,95 |
|
EPS USD | Released Forecast Spread | -2,10 -2,20 4.55% | -2,40 -2,40 0% | -5,40 -2,10 -157.14% | -3,00 -2,40 -25% | -2,40 -1,95 -23.08% | -3,22 -2,27 -42.16% | -5,05 -2,16 -133.8% | -1,01 -0,14 -621.43% | -0,22 | -0,53 | -0,47 | -0,31 | -0,22 | -0,18 |
| Announcement Date | 07/03/22 | 09/05/22 | 08/08/22 | 10/11/22 | 13/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 16/04/24 | - | - | - | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for VBI Vaccines Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VBIV Stock
- Calendar VBI Vaccines Inc.
